N
Norio Kawamoto
Researcher at Gifu University
Publications - 65
Citations - 820
Norio Kawamoto is an academic researcher from Gifu University. The author has contributed to research in topics: Antibody & Major histocompatibility complex. The author has an hindex of 14, co-authored 62 publications receiving 667 citations. Previous affiliations of Norio Kawamoto include Harvard University & Nagara Medical Center.
Papers
More filters
Journal ArticleDOI
Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders
Tomonori Kadowaki,Hidenori Ohnishi,Norio Kawamoto,Tomohiro Hori,Kenichi Nishimura,Chie Kobayashi,Tomonari Shigemura,Shohei Ogata,Yuzaburo Inoue,Tomoki Kawai,Eitaro Hiejima,Masatoshi Takagi,Kohsuke Imai,Ryuta Nishikomori,Shuichi Ito,Toshio Heike,Osamu Ohara,Tomohiro Morio,Toshiyuki Fukao,Hirokazu Kanegane +19 more
Journal ArticleDOI
Propranolol as an alternative treatment option for pediatric lymphatic malformation.
Michio Ozeki,Kaori Kanda,Norio Kawamoto,Hidenori Ohnishi,Akihiro Fujino,Masahiro Hirayama,Zenichiro Kato,Eiichi Azuma,Toshiyuki Fukao,Naomi Kondo +9 more
TL;DR: It is proposed that propranolol may be an alternative therapy option for intractable LM and the relationship between its effectiveness and vascular endothelial growth factor family members (VEGF-A, C and D) is investigated.
Journal ArticleDOI
A Japanese family case with juvenile onset Behçet's disease caused by TNFAIP3 mutation.
Journal ArticleDOI
Age-related changes in intracellular cytokine profiles and Th2 dominance in allergic children.
Norio Kawamoto,Hideo Kaneko,Masao Takemura,Mitsuru Seishima,Satomi Sakurai,Toshiyuki Fukao,Kimiko Kasahara,Shinichi Iwasa,Naomi Kondo +8 more
TL;DR: In allergic diseases, although cord blood showed a Th1‐dominant pattern, it changed to Th2 dominance in childhood, and this may reflect on some genetic background.
Journal ArticleDOI
Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide
Eiji Matsukuma,Yusuke Aoki,Miho Sakai,Norio Kawamoto,Hiroh Watanabe,Shigeki Iwagaki,Yuichiro Takahashi,Ichiro Kawabata,Naomi Kondo,Yasushi Uchida +9 more
TL;DR: The use of OK-432 is reported for treatment of prolonged idiopathic congenital chylothorax in 2 newborn infants who failed to respond to conservative medical therapy, including octreotide injection.